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general population are needed to drive the presen-
tation of patients in clinics. Additionally, training
of primary care physicians in taking an appropriate
medical history and measuring the ABI should
increase the identification of patients, while
increased awareness of the associated atherothrom-
botic risks should encourage more clinically appro-
priate management of risk.
Physicians in secondary care also have a responsi-
bility to ensure that if a patient presents following an
atherothrombotic event at one vascular site, they are
assessed and treated to prevent further events in all
vascular beds. Thus, for example, if a patient presents
following an ischaemic stroke, the patient should also
be assessed for the presence of CAD and PAD, with
or without expressed symptoms, with referrals to
other specialists as appropriate. Recommendations
for follow-up care also need to stress the increased
risk of all types of atherothrombotic event and the
consequent importance of attaining treatment tar-
gets.
The REACH Registry provides high quality data
with high follow-up rates in a large, contemporary,
international cohort in a community setting (1, 2).
However, it does need to be acknowledged that
there are weaknesses to the registry approach
including the potential for recruitment bias.
Although physicians were instructed to recruit con-
secutive patients, adherence to this requirement was
not checked (as it would be in a RCT). In addi-
tion, REACH is not a population-based registry,
therefore, patients are not necessarily representative
of the population as a whole, although efforts were
made to ensure inclusion of representative patients
from every participating country. Furthermore, it
seems likely that physicians choosing to participate
in research initiatives, such as REACH, are more
apt to provide better care. Of course this could
suggest that the level of undertreatment of athero-
thrombosis is actually underestimated by the
REACH registry.
In conclusion, data from REACH indicate that
the profile of PAD needs to be raised so that it is
recognised and investigated. Furthermore, assess-
ment and management of atherothrombotic risk
needs to be both comprehensive and clinically
appropriate to ensure that the mortality and mor-
bidity associated with atherothrombotic disease is
minimised. REACH has provided the information
to enable us to improve our practice and better
serve our patients. Only time will tell if the lessons
are learnt.
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ED ITORIAL
If the shoe fits…footwear and patients with diabetes
Well-fitting footwear performs several important
functions – it offers physical protection and acts as
an environmental barrier for the foot, it provides
biomechanical support and it enables pressure redis-
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tribution across the foot thus reducing the formation
of callus. Ill-fitting footwear has the potential to
cause serious problems, including increased risk of
falls, biomechanical problems and lesions including
callus, blisters and ulcers resulting from friction.
Wearing suitable footwear is particularly important
for patients with diabetes and especially significant
where the patient presents with the signs and symp-
toms of neuropathy.
This issue includes a study by Harrison et al. (1)
that examines whether patients with diabetes are
wearing shoes of the correct size. The study presents
an important finding – that only one-third of patients
with diabetes were wearing appropriate footwear.
This finding is worrying considering the potential
severity of the problems associated with ill-fitting
footwear, and healthcare professionals will want to
reflect upon its implications for their patients, them-
selves and the health service.
The study suggests several reasons why patients
select inappropriate footwear, such as lack of foot-
wear education or the poor availability of broader
fitting shoes. The authors note that there is also a
lack of standardisation of shoe sizes between shoe
manufacturers, patients may have different sized
feet and many patients do not have their feet reg-
ularly measured before purchasing footwear.
Patients with neuropathy often mistakenly select
shoes that are too small, as the sensation caused
by tight fitting footwear is perceived as an appro-
priate fit.
Healthcare professionals therefore have a responsi-
bility to assess footwear and provide advice about
appropriate shoes. Clinicians may want to consider
the quantity and quality of footwear education that
has been provided in the past and possible reasons
why the outcomes of this education appear to be dis-
appointing.
The consequences of ill-fitting footwear have seri-
ous implications for the health service. Ulceration
has numerous socioeconomic repercussions including
impaired quality of life, increased amputation risk
and is also associated with elevated mortality rate
(2). Previous studies have reported that approxi-
mately 20% of ulceration in patients with diabetes is
a result of ill-fitting footwear (3,4). Within the UK
over 1 billion pounds per year is spent on wound
management by the NHS (5).
The study draws attention to two basic issues –
first, what is the true extent of the problem and
second, how may it be resolved? It has long been
suspected that many patients do not wear shoes of
the correct size. A previous study found that 37%
of patients with diabetes in an outpatient clinic
and 24% of general medical outpatients wore incor-
rect footwear (6). This raises concerns about other
high-risk patient categories, such as patients with
rheumatoid arthritis, peripheral vascular disease and
other types of neuropathy. Such patients are also
susceptible to the same myriad of problems as
those with diabetes and their attendant socioeco-
nomic implications. Ideally a series of similar stud-
ies would be required in a variety of geographical
locations and clinical settings to investigate the
scale of the issue.
Resolution of the problem poses a challenge to
healthcare professionals. The authors of the present
study postulate that patients attending specialist clin-
ics would be receiving footwear education and hence
would wear better fitting shoes. It would be interest-
ing to test this assumption.
When purchasing footwear, patients will be influ-
enced by fashion and financial resources. Regretta-
bly, these factors may sometimes displace
consideration of the form and function of the shoe.
It would be very beneficial if manufacturers could
establish an industry standard for the sizing of
footwear with a wider variety of fittings. Retailers
might also help by providing a more efficacious fit-
ting service, based on a greater understanding of
the needs of customers with foot health problems.
There may, therefore, be value in greater liaison
between healthcare professionals and the footwear
industry. If the number of patients wearing ill-fit-
ting shoes is as great as the present study suggests,
there should be a sizeable market for suitable foot-
wear, and considerable economic benefits for the
manufacturers who choose to supply that market.
Improvements in the fitting of footwear have the
potential to reduce the need for provision of clini-
cal care, which would result in savings for the
NHS.
The current study alerts healthcare professionals to
the fact that many patients with diabetes may be
wearing ill-fitting footwear. The authors have there-
fore performed a very valuable service, while high-
lighting a pressing need for further research into this
problematic area.
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